Research for treatments, prevention and a cure
DEBUG INFO [ON]
Page template: single-clinical-trials.php
Search terms : 

Clinical Trials

  • Clinical Studies

General (uncategorized) trials (GEN)


Emtriva access programme

About the programme The purpose of this programme is to provide access to FTC (Emtriva, emtricitabine) as part of an...
Print Friendly, PDF & Email

About the programme

The purpose of this programme is to provide access to FTC (Emtriva, emtricitabine) as part of an ART combination containing tenofovir (Viread®). More information can be found about this programme on the CATIE website.

If you are interested in taking part in this programme, speak to your doctor, who can contact a Gilead Sciences therapeutic specialist for the enrolment form. Upon completion, the form can be faxed to Gilead Sciences at: 1-866-809-0406

Eligibility criteria

Required

  • Have documentation of HIV-1 infection
  • Show that FTC is needed as part of a treatment regimen in combination with tenofovir and other antiretrovirals
  • Have adequate kidney function (creatinine clearance greater than or equal to 50 mL/min)
  • Be 18 years of age or older

Exclusion

  • Have demonstrated previous hypersensitivity to any of the ingredients in Emtriva
  • Be pregnant or breastfeeding

 

Note: Other criteria may apply.

Latest News

CTN at CAHR 2018

| Uncategorized | No Comments

Along with supporting CAHR as a Bronze Sponsor, the CTN is proud to host several important events throughout the week.

CTNPT 029: Group Therapy for People Living with HAND

| Uncategorized | No Comments

Approximately half of the aging HIV-positive population will be affected by HIV-Associated Neurocognitive Disorder (HAND). People with HAND can experience…

In Memoriam: Dr. David Cooper

| Uncategorized | No Comments

The CTN offers condolences to the family, friends, and colleagues of Dr. David Cooper. Dr. Cooper dedicated his life to…

Trans Working Group Working To Remove Health Care Barriers

| Uncategorized | No Comments

  The Prevention and Vulnerable Populations (PVP) Core’s Trans Working Group has submitted their first grant proposal. The proposal is…

Research for treatments, prevention and a cure